STOCK TITAN

Acuity adds up to $400M in unsecured term financing

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Acuity Inc. (AYI) amended its credit agreement to add an unsecured delayed-draw term loan facility of up to $400 million. The proceeds may be used for general corporate purposes, including part of the cash consideration and transaction costs to close the later-date acquisition of Parameter Technologies by subsidiary Acuity Intelligent Spaces US Inc. The facility may be drawn in a single borrowing, subject to conditions, through the earliest of six months after the amendment’s effective date, the acquisition agreement’s outside date, or termination of the commitments.

No loans were outstanding under the facility on November 19, 2026. The facility matures on May 8, 2031. Borrowings bear interest at an adjusted base rate or Term SOFR, plus a margin based, at Acuity’s option, on its leverage ratio or credit rating level. Undrawn commitments accrue a facility fee beginning 91 days after the amendment’s effective date. The revolving credit agreement’s covenants and events of default also apply, and the subsidiaries guaranteeing the revolving loans guarantee this facility.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Term loan facility Up to $400 million Unsecured delayed-draw facility
Draw period limit Six months One of three possible deadlines; measured from the amendment’s effective date
Facility fee start 91 days After the amendment’s effective date, undrawn commitments begin accruing a facility fee
Maturity date May 8, 2031 Term loan facility
delayed draw term loan facility technical
"unsecured delayed draw term loan facility of up to $400 million"
A delayed draw term loan facility is a committed loan that a borrower can tap in one or more installments at specified future times after meeting agreed conditions, rather than receiving the full amount upfront. For investors it matters because it provides a ready source of cash that can change a company’s financial strength, leverage and interest costs when drawn—similar to having a reserved credit line you can use later, which affects liquidity and the risk profile of the business.
Term SOFR financial
"adjusted base rate or Term SOFR, plus ... an applicable margin"
Term SOFR is a benchmark interest rate that reflects the cost of borrowing money over a specific period, based on actual transactions in the financial markets. It is used by lenders and borrowers to set the interest rates on loans and financial contracts, helping to ensure rates are fair and transparent. For investors, understanding term SOFR helps gauge borrowing costs and the overall direction of interest rates in the economy.
facility fee financial
"Undrawn commitments ... will accrue a facility fee"
A facility fee is a charge billed by a hospital or clinic for use of its buildings, equipment and support services when a patient receives care, separate from the fee paid to the treating doctor. For investors, it matters because these charges are a steady revenue stream that can boost margins and cash flow, but they are also sensitive to changes in insurance reimbursement rules and regulatory scrutiny—think of it as a venue rental fee separate from the performer’s paycheck.
leverage ratio financial
"margin is based on ... the Company’s leverage ratio or credit rating level"
Leverage ratio measures how much a company relies on borrowed money compared with its own funds or assets, typically expressed as debt relative to equity or total assets. Like a homeowner with a mortgage, higher leverage can amplify returns when business is strong but also raises the chance of big losses or default if revenue falls, so investors use it to judge financial risk and resilience.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How large is AYI’s new term loan facility?

Acuity’s amendment provides an unsecured delayed-draw term loan facility of up to $400 million. It may be drawn in a single borrowing, subject to conditions; no loans were outstanding under the facility on November 19, 2026.

When can AYI draw the term loan facility?

The facility may be drawn in a single borrowing through the earliest of three deadlines: six months after the amendment’s effective date, the acquisition agreement’s outside date, or termination of the commitments under the credit agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001144215 0001144215 2026-11-19 2026-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 19, 2026

 

 

 

ACUITY INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 001-16583 58-2632672
(State or other jurisdiction of
incorporation)
(Commission File Number) (IRS. Employer
Identification No.)

 

1170 Peachtree Street, N.E., Suite 1200, Atlanta, Georgia 30309

(Address of principal executive offices) (Zip Code)

 

(404) 853-1400

(Registrant’s telephone number, including area code)

 

None

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $.01 par value per share   AYI   New York Stock Exchange

 

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On November 19, 2026, Acuity Inc. (“we,” “our,” “us,” “the Company,” or similar references) entered into an Amendment No. 1 (the “Credit Facility Amendment”) to that certain Credit Agreement, dated as of May 8, 2026, among the Company, the subsidiary borrowers from time to time party thereto, the various lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (the “Existing Credit Agreement”; the Existing Credit Agreement, as amended by the Credit Facility Amendment is referred to herein as the “Credit Agreement”).

 

The Credit Facility Amendment, among other things, provides for an unsecured delayed draw term loan facility of up to $400 million (the “Term Loan Facility”). The Credit Agreement permits the proceeds of the Term Loan Facility to be used for general corporate purposes, including to pay a portion of the cash consideration to close the acquisition of Parameter Technologies by Acuity Intelligent Spaces US Inc., a wholly owned subsidiary of the Company (the “Acquisition”), at a later date, and to pay fees, premiums, expenses and other transaction costs incurred in connection with the Acquisition. The Term Loan Facility may be drawn in a single borrowing, subject to certain conditions, at any time through the earliest of (i) the date that is six months after the effective date of the Credit Facility Amendment, (ii) the “outside date” (as defined in the definitive acquisition agreement for the Acquisition as in effect on the signing date thereof, giving effect to any extension thereto pursuant to the terms of such definitive acquisition agreement as in effect on the signing date thereof) and (iii) the date of the termination of the Term Loan Facility commitments in accordance with the Credit Agreement. On November 19, 2026, no loans were outstanding under the Term Loan Facility.

 

The Term Loan Facility will mature on May 8, 2031, which is the maturity date of the revolving loans and commitments under the Existing Credit Agreement. Borrowings under the Term Loan Facility bear interest at a rate equal to an adjusted base rate or Term SOFR, plus, in each case, an applicable margin. The applicable margin is based on, at the Company’s option, the Company’s leverage ratio or credit rating level. Undrawn commitments under the Term Loan Facility will accrue a facility fee from and including the date that is 91 days after the effective date of the Credit Facility Amendment, which facility fee will be determined, at the Company’s option, by the Company’s leverage ratio or credit rating level.

 

The covenants and events of default that apply to the revolving loans and commitments under the Credit Agreement also apply to the Term Loan Facility, and borrowings under the Term Loan Facility are guaranteed by the subsidiaries of the Company that guarantee the revolving loans and commitments.

 

The foregoing summary of the Credit Facility Amendment, including the transactions contemplated thereby, does not purport to be complete and is qualified in its entirety by reference to the full text of the Credit Facility Amendment, filed herewith as Exhibit 10.1 and incorporated herein by reference.

 

Item  2.03. Creation of a Direct Financial Obligation

 

The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)       Exhibits. The following exhibits are being filed herewith:

 

10.1 Amendment No. 1 to Credit Agreement, dated as of November 19, 2026, among Acuity Inc., the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.
   
104 Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 20, 2026

 

  ACUITY INC.
     
  By: /s/ Karen J. Holcom
    Karen J. Holcom
    Senior Vice President and Chief Financial Officer

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading